Chairs : Pedro MARQUES (PORTUGAL), Juan Manuel JIMÉNEZ VACAS (UNITED KINGDOM)

14:30abstract

Molecular mechanisms of cavernous sinus invasion by pituitary adenomas: in vitro studies and in vivo investigations in a rat model of invasive pituitary tumorigenesis obtained by stereotactic pituitary GC cells injection

Michael BUCHFELDER (GERMANY)
14:39abstract

Circulating microRNAs as predictors for dopamine agonists in hyperprolactinemic patients with pituitary adenoma

Jae Won HONG (KOREA, REPUBLIC OF)
14:48abstract

Effect of a novel somatostatin receptor 5/3 agonist, HTL0030310, on human GH- and ACTH-secreting pituitary adenomas in vitro  

Daniela REGAZZO (ITALY)
14:57abstract

Xq26.3 duplications in X-linked acrogigantism (X-LAG) disrupt a topologically associating domain (TAD) and rewire GPR101-enhancer interactions

Giampaolo TRIVELLIN (ITALY)

Morphological and molecular evidence of macroautophagy in pituitary tumors

Laura CECENARRO (ARGENTINA)

New provocation test using MDMA (‘Ecstasy’) demonstrates Oxytocin deficiency in patients with central diabetes insipidus

Cihan ATILA (SWITZERLAND)
15:24abstract

Association between use of systemic and inhaled glucocorticoids and changes in brain volume and white matter microstructure: a cross-sectional UK Biobank study

Merel VAN DER MEULEN (NETHERLANDS)

CRN04894: an oral, nonpeptide ACTH (MC2) receptor antagonist decreaseds basal and stimulated cortisol secretion in healthy volunteers 

Peter TRAINER (UNITED STATES)

Efficacy and predictive factors of response to immunotherapy in pituitary carcinomas and aggressive pituitary tumors: a French cohort study

Mirela-Diana ILIE (FRANCE)

High prevalence of genetic predisposition in young men and women with lactotrop macroadenomas

Pauline ROMANET (FRANCE)

Prolactinomas: resistance assessment via metabolomic characteristics

Aleksandra SHUTOVA (RUSSIAN FEDERATION)

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience

Miriam VELENO (ITALY)

Clinical and translational evidence of metformin and simvastatin additive antitumor effects in glioblastoma via senescence-state

Miguel E G-GARCIA (SPAIN)

Somatic hotspot variants rarely coexist with germline drivers of Cushing’s disease

Laura C. HERNÁNDEZ-RAMÍREZ (MEXICO)

Clinicopathological characteristics, clinical outcome, and prognostic factors for pituitary carcinomas: lessons from a systematic review of 207 cases

Perrine RAYMOND (FRANCE)

Dissecting the in vitro efficacy of octreotide and cabergoline in GH- and GH/PRL-secreting pituitary tumors

Federico GATTO (ITALY)

Somatostatin and ghrelin systems characterization and therapeutic potential in liver diseases

Natalia HERMAN-SÁNCHEZ (SPAIN)

Neoadjuvant B-RAF and MEK inhibitor targeted therapy for Adult Papillary Craniopharyngiomas: A new treatment paradigm

Francesco CALVANESE (FRANCE)

Volumetric BMD and bone strength estimates on QCT-based finite element analysis are impaired in patients with Cushing’s syndrome in long-term remission

Maria Sol BATULE NALLIM (SPAIN)

Prevalence of somatic SF3B1 mutations in lactotroph tumours

Julia SIMON (GERMANY)

Lysine demethylase KDM1A and ectopic expression of GIP-receptor in somatotroph adenomas

Fanny CHASSELOUP (FRANCE)

Discrimination of pituitary neuroendocrine tumours by Raman spectroscopy

Michel PILOT (GERMANY)

Central diabetes insipidus from a patients’ perspective: management, psychological co-morbidities and re-naming of the condition

Cihan ATILA (SWITZERLAND)

Circulating miR-28-5p is a potential biomarker of sarcopenia in patients with Cushing’s syndrome in remission

Elena CASADEMUNT (SPAIN)

The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults

Sophie MONNERAT (SWITZERLAND)

Resistance to cabergoline treatment in human primary non-functioning pituitary tumour cells

Federica BEGALLI (UNITED KINGDOM)

Cabergoline add-on therapy in patients with uncontrolled acromegaly under somatostatin analogues – a multicenter, retrospective, cohort study of non-irradiated patients applying current criteria for disease control  

Sandrine A. URWYLER (UNITED KINGDOM)

Long-term treatment with oral paltusotine for acromegaly: Results from the ACROBAT Advance study 

Harpal RANDEVA (UNITED KINGDOM)

Debio 4126, a new 3-month octreotide formulation, provides sustained release of octreotide, as well as enhanced bioavailability and similar suppression of insulin-like growth factor 1 (IGF-1), compared to monthly Sandostatin LAR in healthy volunteers - interim results

Anne BELLON (SWITZERLAND)

Genetic aspects of adrenal incidentalomas

Gulrukh ALIMOUKHAMEDOVA (UZBEKISTAN)

Outcomes in patients receiving oral octreotide capsules related to time from last somatostatin receptor ligand injection: analysis from the MPOWERED Phase 3 study

Djuro MACUT (SERBIA)

Clinical-imagine asessment of agressive pituitary adenomas

Ozoda AZIMOVA (UZBEKISTAN)

Patterns of somatostatin receptor ligand dosage and titration in patients with acromegaly: a real-world evidence study

Maria FLESERIU (UNITED STATES)

First-generation somatostatin receptor ligands in the treatment of acromegaly: real-world patient journey

Thierry BRUE (FRANCE)

Treatment of hypothalamic obesity with GLP-1 agonists and extreme diet in a patient with hypothalamic inflammatory infiltration

Eva Marie ERFURTH (SWEDEN)

Clinical case of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) with uncertain localization

Ekaterina PIGAROVA (RUSSIAN FEDERATION)

Vanishing pituitary lesion with intermittent central adrenal insufficiency

Monica Livia GHEORGHIU (ROMANIA)

ACROMEGALY DUE TO  A GH-SECRETING PITUITARY ADENOMA IN THE SPHENOID SINUS

Guillermo SERRA SOLER (SPAIN)

Morning and evening concentrations of salivary aldosterone and cortisol throughout the menstrual cycle in healthy women

Daniela JEZOVA (SLOVAKIA)

Observation of bone mineral density in Cushing syndrome

Gulchekhra NARIMOVA (UZBEKISTAN)

The various clinical outcomes of giant prolactinomas in men

Anna BOGUSLAWSKA (POLAND)

The endoscopic endonasal resection of giant pituitary neuroendocrine tumors - case series from the referral pituitary center.

Jacek KUNICKI (POLAND)

Results of surgical treatment of the Rathke cleft cysts with endoscopic endonasal cyts evacualtion – clinical series from pituitary referral center.

Jacek KUNICKI (POLAND)

Impact of the micro nutriments’ deficit on the functional disorders for diabetic menopause women.

Olfa BERRICHE (TUNISIA)

Health-Related Quality of Life Burden in Endogenous Cushing’s Syndrome: A Retrospective Medical Chart Audit Study

Eliza GEER (UNITED STATES)

Gonadotroph Adenomas. A Single-Center Study of 112 cases.

Mariana SOLOVEY (UKRAINE)

Hypothalamic neuropeptides as biomarkers of diabetes insipidus.

Nino KATAMADZE (RUSSIAN FEDERATION)

A rare case of dermoid cyst as a cause of short stature, precocious puberty, optic nerve hypoplasia, and hypopituitarism

Anna BOGUSLAWSKA (POLAND)

Cardio-metabolic risk in acromegaly patients: a study of cardiac magnetic resonance imaging

Alessia COZZOLINO (ITALY)

Age-dependent differences in acromegaly at diagnosis

Suleyman Nahit SENDUR (TURKEY)

Impaired insulin secretion without changes in insulin sensitivity explains hyperglycemia in patients with acromegaly treated by pasireotide LAR

Peter WOLF (AUSTRIA)

Pituitary dysfunction in histiocytosis at diagnosis and follow-up: a single tertiary center experience

Burcin GONUL IREMLI (TURKEY)

Cardio-metabolic risk in Cushing’s syndrome patients: a study of cardiac magnetic resonance imaging

Dario DE ALCUBIERRE (ITALY)

Resistant and aggressive prolactinoma treated with temozolomide

Catarina CIDADE-RODRIGUES (PORTUGAL)

First line treatment with 177Lu-Dotatate in a patient with miliary liver metastases and carcinoid syndrome from a midgut neuroendocrine tumor

Aristidis DIAMANTOPOULOS (GREECE)

Hpa axis disregulation due to impaired glucocorticoid negative feedback in patients with chronic kidney disease

Felicia A HANZU (SPAIN)

A novel flow cytometry-based method to study lymphocytes present in low cell numbers infiltrating non-functional and growth-hormone secreting pituitary adenomas

Oriana MAZZITELLI (MALTA)

Dilated cardiomyopathy, a rare and reversible manifestation of the glucagonoma syndrome

Vasiliki ANTONOPOULOU (GREECE)

Thyrotropin-secreting pituitary adenoma: a case in which postoperative surveillance made a difference

Ariana MAIA (PORTUGAL)

Cyclin-dependent kinase 4 (cdk4) regulates the myelin sheath of hypothalamic neurons

Sarah GELLER (SWITZERLAND)

RELATIONSHEEP BETWEEN COVID-19 AND VITAMIN D.

Umida MIRZAEVA (UZBEKISTAN)

Late-night salivary cortisol versus urinary free cortisol in the monitorization of cushing's syndrome patients treated with steroidogenesis inhibitors

Arturo VEGA-BEYHART (SPAIN)

Forty-two patients with thyrotropin-secreting pituitary adenomas: clinical characteristics and therapeutic outcomes

Diana TRUKHINA (RUSSIAN FEDERATION)

metabolically healthy obesity: and if the key was the quality of sleep?

Rym BEN OTHMAN (TUNISIA)

Impact of preanalytical conditions and biological variables on urinary concentrations of soluble alpha klotho, a novel biomarker of growth hormone activity

Júnia ROL SCHWEIZER (GERMANY)

“Complexity of Carney complex”: a case series form a single expert center for rare endocrine diseases

Aneliya NANKOVA (BULGARIA)

Assessing the immune gene and cellular networks within human non-functioning and growth-hormone secreting pituitary adenomas via transcriptomic and pathway analysis

Emma Jayne SPITERI (MALTA)

The partial response to first generation somatostatin analogues guides the choice and may predict the outcome of second line therapies with pasireotide lar: data from a real life experience

Sara MENOTTI (ITALY)

Prospective assessment of 11C-Methionine PET-MRI performance to localize corticotroph pituitary microadenomas

Anthime FLAUS (FRANCE)

Features of carbohydrate disorders in Cushing Syndrome 

Malika NARIMOVA (UZBEKISTAN)

Declining hemoglobin levels may serve as a marker for disease duration in male macroprolactinoma: a proof-of-concept retrospective study

Yaron RUDMAN (ISRAEL)

A pituitary macroadenoma revealed by an ischemic stroke: a case report

Khaoula GORGI (MOROCCO)

Pituitary adenoma consistency affects postoperative hormone function: a retrospective study

Dario DE ALCUBIERRE (ITALY)

Comparative transcriptomics of functional vs non-functional pituitary neuroendocrine tumors

Nikolai Paul PACE (MALTA)

Incidental Discovery of Pituitary Insufficiency after Non-pituitary Surgery

Tamari KHUTSISHVILI (GEORGIA)

Cushing syndrome in older women: age-related differences in disease origin and clinical manifestations

Amit AKIROV (ISRAEL)

The immune cell profiling in acromegalic patients. Preliminary results from a case-control study

Tiziana FEOLA (ITALY)

macroprolactinoma in a postmenopausal woman: a case report

Khaoula GORGI (MOROCCO)

Predictors of response to steroid therapy in primary anterior or pan-hypophysitis

Yash CHAUHAN (INDIA)

Potential benefits of sleep medicine in acromegalics: preliminary results from a case-control study

Tiziana FEOLA (ITALY)

Tumor volume assessment in consecutive newly-diagnosed patients with acromegaly- evaluation of two methods

Magdalena GODLEWSKA (POLAND)

MALFD prevalence in a cohort of patients with Cushing´s Disease

Pablo REMON-RUIZ (SPAIN)

A rare aggressive tumor of the sellar region: atypical teratoid/rhabdoid tumor

Banu ERTURK (TURKEY)

Thyrotrophynoma induced hyperthyroidism: what is the best management?

Helena URBANO FERREIRA (PORTUGAL)

Pituitary macroadenoma and pregnancy: a case report

Khaoula GORGI (MOROCCO)

Gender Differences in Pituitary Somatotropinomas Size After Radiation Therapy

Saodat ISAEVA (UZBEKISTAN)

ACTH-dependent severe hypercortisolaemia treated with osilodrostat and etomidate combination therapy - a case report. 

Lukasz DZIALACH (POLAND)

MEN-1 phenotype or a series of unfortunate events?

Maria Inês ALEXANDRE (PORTUGAL)

The challenging  management of aggressive, giant silent corticotroph PiTNET in a young male patient

Anna BOGUSLAWSKA (POLAND)

Hyperprolactinemia is common in geriatric patients: A descriptive study

Suleyman Nahit SENDUR (TURKEY)

Increased innervation of the hypothalamic paraventricular nucleus by the AgRP and α-MSH axonal projections in germ-free mice

Serguei FETISSOV (FRANCE)

Salivary cortisol concentrations in children suffering from depression treated with omega-3 fatty acids

Henrieta ORAVCOVÁ (SLOVAKIA)

Adult Langerhans’ cell histiocytosis as polidipsic - poliuric syndrome in Covid Times

Adelqui SANHUEZA (CHILE)

 Telemedicine as a good tool for monitoring Acromegalic outpatients during COVID-19 pandemic

Luciana NAVES (BRAZIL)

Osilodrostat in patients with persistent or recurrent Cushing's Disease: a real-life single center experience  

Aristidis DIAMANTOPOULOS (GREECE)

Obesity and reproductive disorders in women.

Dilafruz MAKSUDOVA (UZBEKISTAN)

Clinical features of non-functioning sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study

Tiziana FEOLA (ITALY)

Cardiac morphology and function in adult patients with growth hormone deficiency – a cross-sectional case-control study

Ivayla UZUNOVA (BULGARIA)

Optimization of medical therapy in patients with acromegaly

Evgeny PRONIN (RUSSIAN FEDERATION)

TGFBR3L in Non-Functioning Pituitary Neuroendocrine Tumours

Kristin Astrid ØYSTESE (NORWAY)

Overnight dexamethasone suppression test: a valuable measure of medical treatment efficacy in ACTH-dependent Cushing’s Syndrome  

Sofia GOULOPOULOU (GREECE)

Ectopic ACTH syndrome in lung carcinoids – a case series

Sara RIBEIRO (PORTUGAL)

MEDICAL TREATMENT IN CUSHING'S DISEASE - EXPERIENCE OF A TERTIARY CARE CENTRE

Catarina CIDADE-RODRIGUES (PORTUGAL)

Immunohistochemichal expression of ephrin receptor (EPH)-A4, -A5, -B2, -B5 and SSTR2a and -5  in pituitary lesions

Eirini PAPADIMITRIOU (GREECE)

Cushing syndrome and pregnancy: a single tertiary center experience

Burcin GONUL IREMLI (TURKEY)

Baseline clinical and treatment characteristics in a Dutch national cohort of patients with prolactinoma

Iris PELSMA (NETHERLANDS)

Stem cell markers are associated with the regulators of the gonadotroph axis in gonadotroph NF-PitNETs

Kristin Astrid ØYSTESE (NORWAY)

Predictive Factors for Acromegaly Remission after Transsphenoidal Surgery in a Portuguese tertiary care center

Ariana MAIA (PORTUGAL)

Ectopic production of ACTH in the adrenal medulla (clinical case)

Anna MOTRENKO (RUSSIAN FEDERATION)

  " Characteristics of the clinical picture of Type III Polyglandular Autoimmune Syndrome ” 

Gulzoda NEGMATOVA (UZBEKISTAN)

The relatives’ quality of life and perception of the disease differ between Acromegaly and Cushing’s syndrome in remission

Frederic CASTINETTI (FRANCE)

Craniopharyngiomas in Adults : a cohort study of 151 patients

Thomas CUNY (FRANCE)

Contribution of functional imaging in the follow-up of a patient with pituitary macroadenoma, paraganglioma, renal tumor, and SDHC gene variant.  

Brigitte DELEMER (FRANCE)

Case report: Safety and usefulnes of Metyrapone for the control of hypercortisolism in a complex patient with Cushing´s disease

Pablo REMON-RUIZ (SPAIN)

Cushing’s syndrome in the elderly: data from ercusyn  

Vincent AMODRU (SPAIN)

 Characteristics of disorders of reproductive function in women of fertile age with  Cushing syndrome in the Republic of Uzbekistan

Oydin IRGASHEVA (UZBEKISTAN)

Pituitary apoplexy and COVID-19 infection/vaccination

Ludovica ALIBERTI (ITALY)

CLINICAL FEATURES OF ACROMEGALY IN THE KHOREZM REGION

Anorjon ALIMOVA (UZBEKISTAN)

Somatotroph pituitary tumor signal intensity in T-2 weighted pituitary MR images- quantitative assessment of the parameter and its clinical implications in consecutive newly-diagnosed patients with acromegaly.

Magdalena GODLEWSKA (POLAND)

Patients with atopy exhibit attenuated neuroendocrine response during psychosocial stress  

Natasa HLAVACOVA (SLOVAKIA)

Treatment of Cushing’s disease (CD) after primary failure of transsphenoidal surgery or recurrence: evaluation of long-term control by drug treatment

Olivier CHABRE (FRANCE)

Epicardial and pericardial adiposity without myocardial steatosis in Cushing’s syndrome

Peter WOLF (AUSTRIA)

Impact of a specific rehabilitation program on the quality of life of patients with a Cushing's syndrome

Laurence HAVÉ (FRANCE)

Circadian clock and muscle wasting associated with impaired insulin signalling: in vitro effect of hydrocortisone circadian administrations.

Claudia PIVONELLO (ITALY)

Functional characterization of beta-arrestin 1 in neuroendocrine tumor cell lines

Claudia CAMPANA (NETHERLANDS)

CLINICAL AND LABORATORY CHARACTERISTICS OF HYPERANDROGENISM IN WOMEN WITH HYPERPROLACTINEMIA

Diyora MUKHAMMEDAMINOVA (UZBEKISTAN)

Gonadotroph Pituitary Adenoma or Andropause

Efstathios DIVARIS (GREECE)

Already have your IDs?